Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in two segments, Health Plans and Other. As of December 31, 2020, it served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 15 states. The company offers its health care services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. Molina Healthcare, Inc. was founded in 1980 and is headquartered in Long Beach, California.
IPO Year: 2003
Exchange: NYSE
Website: molinahealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/30/2024 | $405.00 | Outperform | Robert W. Baird |
| 3/28/2024 | $439.00 | Neutral → Underperform | BofA Securities |
| 3/6/2024 | $437.00 | Equal Weight | Barclays |
| 2/15/2024 | $367.00 → $420.00 | Underweight → Equal Weight | Wells Fargo |
| 6/20/2023 | $310.00 | Neutral | UBS |
| 4/21/2023 | $354.00 | Overweight | Cantor Fitzgerald |
| 12/13/2022 | $388.00 | Underperform → Neutral | BofA Securities |
| 10/3/2022 | $360.00 | Overweight | JP Morgan |
| 6/17/2022 | $310.00 | Hold | Loop Capital |
| 5/26/2022 | $355.00 → $335.00 | Buy → Underperform | BofA Securities |
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced the closing of its previously announced offering of $750 million aggregate principal amount of 6.250% senior notes due 2033 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The Notes bear interest at a rate of 6.250% per annum. Interest on the Notes is payable semi-annually in arrears on January 15 and July 15 of each year, commencing July 15, 2025, and accrues from N
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it priced $750 million aggregate principal amount of its 6.250% senior notes due 2033 (the "Notes") to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The offering is expected to close on or about November 18, 2024 (such actual closing date, the "Settlement Date"), subject to the satisfaction of customary closing conditions. The Notes will not be guaranteed by any of the C
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it intends to privately offer, subject to market and other conditions, $500 million aggregate principal amount of senior notes due 2033 (the "Notes"). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the "Securities Act"). The initial purchasers will sell the Notes only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act and to certain persons outside the United States in reliance on Regulation S under the Securities Act ("Regulation S"). The Notes will not be guaranteed by any of the Company's sub
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,694 $ 8,240 $ 28,644 $ 24,167 Total Revenue $ 10,340 $ 8,548 $ 30,151
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that the Michigan Department of Health and Human Services (MDHHS) has awarded a contract to Molina's health plan subsidiary, Molina Healthcare of Michigan, to provide a Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP). The new benefit plan, MI Coordinated Health, will be available to individuals enrolled in both Medicare and Medicaid. Molina confirmed it was awarded the contract in six service regions. Molina currently serves two regions in the existing Michigan Health Link program, the state's current platform for serving dual eligible members. The go-live date for the new contract is expected to b
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") today announced it will issue its earnings release for the third quarter ending September 30, 2024, after the market closes on Wednesday, October 23, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, October 24, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 7014206. A telephonic replay of the conference call will be available through Thursday, October 31, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5232318. A live broadcast of Molina Healthcare's conference call will be avai
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that Senior Executive Vice President and Chief Financial Officer, Mark Keim, will assume an expanded role which will now include leadership of the Company's Medicaid Health Plans and Marketplace business. His responsibilities as Chief Financial Officer of the enterprise remain unchanged. Keim, 59, joined Molina in January of 2018 and was named Chief Financial Officer in February 2021. "Mark has been an extraordinary leader not only in the realm of finance, but also in strategic development and operations," said Molina President and CEO Joe Zubretsky. "Formally extending that leadership and results orientation
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that its Board of Directors has entered into a contract amendment with President and Chief Executive Officer, Joe Zubretsky, designed to secure Mr. Zubretsky's tenure through at least the end of 2027. Zubretsky, 67, joined Molina as President and Chief Executive Officer in November of 2017. "Under Joe's leadership we have the right strategy, great execution, and have created significant value for shareholders," said Dale Wolf, Molina's Chairman of the Board. "We are delighted that Joe will be at the helm for the foreseeable future to continue to do so." Under this contract amendment, Zubretsky was awarded a s
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,446 $ 8,042 $ 18,950
Transaction expands Molina's Government managed care presence into Connecticut and is expected to add $1.00 per share to new store embedded earnings1 Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that it has entered into a definitive agreement to acquire ConnectiCare Holding Company, Inc. ("ConnectiCare"), a wholly owned subsidiary of EmblemHealth, Inc. The purchase price for the transaction is $350 million, representing 25% of expected 2024 premium revenue of $1.4 billion. ConnectiCare is a leading health plan in the state of Connecticut serving approximately 140,000 members across Marketplace, Medicare, and certain commercial products as of June 30, 20
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
10-Q - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,694 $ 8,240 $ 28,644 $ 24,167 Total Revenue $ 10,340 $ 8,548 $ 30,151
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") today announced it will issue its earnings release for the third quarter ending September 30, 2024, after the market closes on Wednesday, October 23, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, October 24, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 7014206. A telephonic replay of the conference call will be available through Thursday, October 31, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5232318. A live broadcast of Molina Healthcare's conference call will be avai
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,446 $ 8,042 $ 18,950
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2024, after the market closes on Wednesday, July 24, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, July 25, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 8508329. A telephonic replay of the conference call will be available through Thursday, August 1, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5266367. A live broadcast of Molina Healthcare's conference call will be available on the Company's website, molinah
Reaffirms Full Year 2024 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.73. Financial results are summarized below: Three months ended March 31, 2024 2023 (In millions, except per-share results) Premium Revenue $9,504 $7,885 Total Revenue $9,931 $8,149 GAAP: Net Income $301 $321 EPS – Diluted
Molina Healthcare, Inc. (NYSE:MOH) today announced details for the release of its results for the first quarter ending March 31, 2024. Molina Healthcare will issue its earnings release for the first quarter ending March 31, 2024, after the market closes on Wednesday, April 24, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, April 25, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 0974846. A telephonic replay of the conference call will be available through Thursday, May 9, 2024, by dialing (877) 344-7529 and entering the confirmation number, 7039934. A live
Introduces Full Year 2024 Revenue and Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported fourth quarter 2023 GAAP earnings per diluted share of $3.70 and adjusted earnings per diluted share of $4.38. The Company also reported full year 2023 GAAP earnings per diluted share of $18.77 and adjusted earnings per diluted share of $20.88. Financial results are summarized below: Three months ended Year ended December 31, December 31, 2023 2022 2023 2022 (In millions, except per-s
Molina Healthcare, Inc. (NYSE:MOH) today announced details for the release of its results for the fourth quarter and year ended December 31, 2023. Molina Healthcare will issue its earnings release for the fourth quarter and year ended December 31, 2023, after the market closes on Wednesday, February 7, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, February 8, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4221213. A telephonic replay of the conference call will be available through Thursday, February 15, 2024, by dialing (877) 344-7529 and entering the confi
Affirms Full Year 2023 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2023 GAAP earnings per diluted share of $4.21 and adjusted earnings per diluted share of $5.05. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 (In millions, except per-share results) Premium Revenue $8,240 $7,636 $24,167 $22,966 Total Revenue
Molina Healthcare, Inc. (NYSE:MOH) today announced details for the release of its results for the third quarter ending September 30, 2023. Molina Healthcare will issue its earnings release for the third quarter ending September 30, 2023, after the market closes on Wednesday, October 25, 2023, and will host a conference call and webcast to discuss the earnings release on Thursday, October 26, 2023, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 2183620. A telephonic replay of the conference call will be available through Thursday, November 2, 2023, by dialing (877) 344-7529 and entering the confirmation number, 3
Robert W. Baird initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $405.00
BofA Securities downgraded Molina Healthcare from Neutral to Underperform and set a new price target of $439.00
Barclays initiated coverage of Molina Healthcare with a rating of Equal Weight and set a new price target of $437.00
Wells Fargo upgraded Molina Healthcare from Underweight to Equal Weight and set a new price target of $420.00 from $367.00 previously
UBS initiated coverage of Molina Healthcare with a rating of Neutral and set a new price target of $310.00
Cantor Fitzgerald initiated coverage of Molina Healthcare with a rating of Overweight and set a new price target of $354.00
BofA Securities upgraded Molina Healthcare from Underperform to Neutral and set a new price target of $388.00
JP Morgan resumed coverage of Molina Healthcare with a rating of Overweight and set a new price target of $360.00
Loop Capital initiated coverage of Molina Healthcare with a rating of Hold and set a new price target of $310.00
BofA Securities downgraded Molina Healthcare from Buy to Underperform and set a new price target of $335.00 from $355.00 previously
Cantor Fitzgerald analyst Sarah James reiterates Molina Healthcare (NYSE:MOH) with a Overweight and maintains $406 price target.
Molina Healthcare (NYSE:MOH) reported quarterly earnings of $5.86 per share which beat the analyst consensus estimate of $5.55 by 5.59 percent. The company reported quarterly sales of $9.880 billion which beat the analyst consensus estimate of $9.746 billion by 1.38 percent. This is a 18.65 percent increase over sales of $8.327 billion the same period last year.
TD Cowen analyst Gary Taylor maintains Molina Healthcare (NYSE:MOH) with a Buy and lowers the price target from $412 to $351.
Jefferies analyst David Windley maintains Molina Healthcare (NYSE:MOH) with a Hold and lowers the price target from $354 to $297.
Cantor Fitzgerald analyst Sarah James reiterates Molina Healthcare (NYSE:MOH) with a Overweight and maintains $406 price target.
Molina Healthcare (NYSE:MOH) has outperformed the market over the past 10 years by 9.91% on an annualized basis producing an average annual return of 20.82%. Currently, Molina Healthcare has a market capitalization of $16.97 billion. Buying $1000 In MOH: If an investor had bought $1000 of MOH stock 10 years ago, it would be worth $6,555.00 today based on a price of $289.60 for MOH at the time of writing. Molina Healthcare's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automat